Diversified Healthcare Trust (NASDAQ:DHC) traded with a subtraction of -$0.12 to $1.91 on Thursday, a downside of -5.91 percent. An average of 1,045,751 shares of common stock have been traded in the last five days. There was a fall of -$0.29 in the past week, and it reached a new high 19 times over the past 12 months. The last 20 days have seen an average of 2,095,538 shares traded, while the 50-day average volume stands at 1,801,719.
DHC stock has decreased by -31.05% in the last month. The company shares reached their 1-month lowest point of $1.85 on 09/28/23. With the stock rallying to its 52-week high on 08/08/23, shares of the company touched a low of $0.61 and a high of $3.30 in 52 weeks. It has reached a new high 21 times so far this year and achieved 195.30% or $1.25 in price. In spite of this, the price is down -42.12% from the 52-week high.
Valuation Metrics
Diversified Healthcare Trust (DHC) has a trailing price-to-earnings (P/E) ratio of N/A for the broader industry. The stock’s beta is 1.91. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.34, the price-to-book (PB) ratio at 0.18.
Financial Health
Further, the company has a long term debt to equity ratio of 1.12 and a total debt to equity ratio of 1.12 for the quarter ending June 29. Its gross profit as reported stood at -$93.82 million compared to revenue of $1.28 billion.
Earnings Surprise
For the three-month period that ended June 29, Diversified Healthcare Trust had $450.0 million in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$72.57 million in the quarter, while revenues of -$52.66 million were shrunk -50.72%. The analyst consensus anticipated Diversified Healthcare Trust’s latest quarter earnings to come in at -$0.23 per share, but it turned out to be -$0.3, a -30.40% surprise. For the quarter, EBITDA amounted to $37.64 million. At the end of the quarter ending June 29, Diversified Healthcare Trust’s stock balance sheet showed total debt was $2.81 billion. Shareholders own equity worth $239.79 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Diversified Healthcare Trust (DHC) price momentum. RSI 9-day as of the close on 27 September was 27.73%, suggesting the stock is oversold, with historical volatility in this time frame at 101.35%.
As of today, DHC’s price is $2.15 -13.24% or -$0.29 from its 5-day moving average. DHC is currently trading -36.24% lower than its 20-day SMA and +115.62% higher than its 100-day SMA. However, the stock’s current price level is -30.66% below the SMA50 and +147.17% above the SMA200.
The stochastic %K and %D were 11.44% and 21.58%, respectively, and the average true range (ATR) was 0.20. With the 14-day stochastic at 7.35% and the average true range at 0.20, the RSI (14) stands at 32.96%. The stock has reached -0.16 on the 9-day MACD Oscillator while the 14-day reading was at -0.21.
Analyst Ratings
Wells Fargo downgraded Diversified Healthcare Trust (NASDAQ: DHC) to a an Underweight rating in its most recent analyst report. Previously, the stock was rated as an Equal weight.
What is DHC’s price target for the next 12 months?
Analysts predict a range of price targets between $0.90 and $4.50, with a median target of $2.70. Taking a look at these predictions, the average price target given by analysts for Diversified Healthcare Trust (DHC) stock is $2.70.
